• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肢端肥大症中的生长激素和胰岛素信号传导:手术与生长抑素类似物治疗的影响

Growth Hormone and Insulin Signaling in Acromegaly: Impact of Surgery Versus Somatostatin Analog Treatment.

作者信息

Dal Jakob, Høyer Katrine Lundby, Pedersen Steen Bønløkke, Magnusson Nils Erik, Bjerring Peter, Frystyk Jan, Møller Niels, Jessen Niels, Jørgensen Jens Otto Lunde

机构信息

Medical Research Laboratory (J.D., K.L.H., S.B.P., N.E.M., J.F., N.M., J.O.L.J.), Department of Clinical Medicine, Health, Aarhus University, and Department of Endocrinology, Aarhus University Hospital, 8000 Aarhus, Denmark; Department of Clinical Pharmacology (N.J.), University of Aarhus, 8000 Aarhus, Denmark; and Mølholm Research (P.B.), Mølholm Hospital, 7100 Vejle, Denmark.

出版信息

J Clin Endocrinol Metab. 2016 Oct;101(10):3716-3723. doi: 10.1210/jc.2016-1806. Epub 2016 Jul 28.

DOI:10.1210/jc.2016-1806
PMID:27466699
Abstract

CONTEXT

Somatostatin analogs (SAs) used in acromegaly to suppress GH secretion and tumor growth also suppress insulin secretion and may impact GH signaling.

OBJECTIVE

To compare GH and insulin signaling after iv GH exposure in acromegalic patients controlled by surgery (n = 9) or SA (n = 9).

DESIGN

Each patient was studied for 3 hours after an overnight fast (t = -60 to 120 minutes). GH was administered at t = 0 minutes; muscle and fat biopsies were obtained at t = 0 minutes and at t = 30 minutes (muscle) and t = 120 minutes (fat). Interstitial fluid was obtained from skin suction blisters (t = 0 minutes).

MAIN OUTCOME MEASURES

GH and insulin signalling in muscle and fat. GH and IGF-1 in serum and interstitial fluid; insulin and free fatty acids in serum.

RESULTS

The groups were comparable as regards GH and IGF-1. The SA group exhibited higher free fatty acid and glucose levels; basal suppressor of cytokine signaling protein 1 (SOCS1) mRNA in fat was increased in the SA group and correlated positively with SA dose (r = 0.54; P = .04). GH-induced GH signalling (pSTAT5b) in muscle occurred in both groups together with increased expression of SOCS and CISH genes. GH-induced pAKTthr was observed in SA patients. In both groups, mRNA expression of phosphatase and tensin homolog, a suppressor of insulin signaling, increased in fat after GH.

CONCLUSION

  1. Signatures of GH and insulin signaling differ as a function of acromegaly treatment modality. 2) Extra-pituitary effects of SA may account for this. 3) The clinical implications remain to be investigated.
摘要

背景

用于肢端肥大症以抑制生长激素(GH)分泌和肿瘤生长的生长抑素类似物(SA)也会抑制胰岛素分泌,并可能影响GH信号传导。

目的

比较手术控制(n = 9)或SA(n = 9)治疗的肢端肥大症患者静脉注射GH后的GH和胰岛素信号传导。

设计

每位患者在禁食过夜后(时间t = -60至120分钟)接受3小时研究。在t = 0分钟时注射GH;在t = 0分钟、t = 30分钟(肌肉)和t = 120分钟(脂肪)时获取肌肉和脂肪活检样本。从皮肤吸引水疱中获取组织间液(t = 0分钟)。

主要观察指标

肌肉和脂肪中的GH和胰岛素信号传导。血清和组织间液中的GH和胰岛素样生长因子-1(IGF-1);血清中的胰岛素和游离脂肪酸。

结果

两组在GH和IGF-1方面具有可比性。SA组的游离脂肪酸和葡萄糖水平较高;SA组脂肪中细胞因子信号传导抑制蛋白1(SOCS1)mRNA的基础水平升高,且与SA剂量呈正相关(r = 0.54;P = 0.04)。两组肌肉中均出现GH诱导的GH信号传导(磷酸化信号转导及转录激活因子5b,pSTAT5b),同时SOCS和CISH基因的表达增加。SA患者中观察到GH诱导的磷酸化苏氨酸蛋白激酶B(pAKTthr)。在两组中,GH作用后脂肪中胰岛素信号传导抑制因子磷酸酶和张力蛋白同源物(PTEN)的mRNA表达均增加。

结论

1)GH和胰岛素信号传导特征因肢端肥大症治疗方式而异。2)SA的垂体外作用可能是其原因。3)其临床意义仍有待研究。

相似文献

1
Growth Hormone and Insulin Signaling in Acromegaly: Impact of Surgery Versus Somatostatin Analog Treatment.肢端肥大症中的生长激素和胰岛素信号传导:手术与生长抑素类似物治疗的影响
J Clin Endocrinol Metab. 2016 Oct;101(10):3716-3723. doi: 10.1210/jc.2016-1806. Epub 2016 Jul 28.
2
Growth hormone signaling in vivo in human muscle and adipose tissue: impact of insulin, substrate background, and growth hormone receptor blockade.人体肌肉和脂肪组织中生长激素信号传导的体内研究:胰岛素、底物背景及生长激素受体阻断的影响
J Clin Endocrinol Metab. 2008 Jul;93(7):2842-50. doi: 10.1210/jc.2007-2414. Epub 2008 May 6.
3
Acute peripheral metabolic effects of intraarterial leg infusion of somatostatin in healthy young men.健康年轻男性经股动脉腿部输注生长抑素的外周急性代谢效应。
J Clin Endocrinol Metab. 2011 Aug;96(8):2581-9. doi: 10.1210/jc.2011-0592. Epub 2011 Jun 1.
4
Targeting either GH or IGF-I during somatostatin analogue treatment in patients with acromegaly: a randomized multicentre study.在肢端肥大症患者的生长抑素类似物治疗期间靶向生长激素(GH)或胰岛素样生长因子-I(IGF-I):一项随机多中心研究。
Eur J Endocrinol. 2018 Jan;178(1):65-74. doi: 10.1530/EJE-17-0546. Epub 2017 Oct 9.
5
Reversible insulin resistance in muscle and fat unrelated to the metabolic syndrome in patients with acromegaly.肢端肥大症患者肌肉和脂肪中的胰岛素抵抗具有可逆性,且与代谢综合征无关。
EBioMedicine. 2022 Jan;75:103763. doi: 10.1016/j.ebiom.2021.103763. Epub 2021 Dec 17.
6
Conventional and novel biomarkers of treatment outcome in patients with acromegaly: discordant results after somatostatin analog treatment compared with surgery.肢端肥大症患者治疗结果的传统和新型生物标志物:与手术相比,生长抑素类似物治疗后的结果不一致。
Eur J Endocrinol. 2010 Nov;163(5):717-26. doi: 10.1530/EJE-10-0640. Epub 2010 Sep 2.
7
Fat content in liver and skeletal muscle changes in a reciprocal manner in patients with acromegaly during combination therapy with a somatostatin analog and a GH receptor antagonist: a randomized clinical trial.肢端肥大症患者在生长抑素类似物和生长激素受体拮抗剂联合治疗期间,肝和骨骼肌中的脂肪含量呈相互反向变化:一项随机临床试验。
J Clin Endocrinol Metab. 2012 Apr;97(4):1227-35. doi: 10.1210/jc.2011-2681. Epub 2012 Feb 1.
8
Growth hormone signaling in muscle and adipose tissue of obese human subjects: associations with measures of body composition and interaction with resveratrol treatment.肥胖患者肌肉和脂肪组织中的生长激素信号转导:与身体成分测量指标的相关性及与白藜芦醇治疗的相互作用。
J Clin Endocrinol Metab. 2014 Dec;99(12):E2565-73. doi: 10.1210/jc.2014-2215.
9
Impact of fasting on growth hormone signaling and action in muscle and fat.禁食对肌肉和脂肪中生长激素信号传导及作用的影响。
J Clin Endocrinol Metab. 2009 Mar;94(3):965-72. doi: 10.1210/jc.2008-1385. Epub 2008 Dec 9.
10
Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly.垂体生长激素分泌瘤的部分手术切除可增强肢端肥大症患者对生长抑素类似物的反应。
J Clin Endocrinol Metab. 2006 Jan;91(1):85-92. doi: 10.1210/jc.2005-1208. Epub 2005 Nov 1.

引用本文的文献

1
Interpreting growth hormone and IGF-I results using modern assays and reference ranges for the monitoring of treatment effectiveness in acromegaly.使用现代检测方法和参考范围解读生长激素和 IGF-1 结果,以监测肢端肥大症的治疗效果。
Front Endocrinol (Lausanne). 2023 Oct 25;14:1266339. doi: 10.3389/fendo.2023.1266339. eCollection 2023.
2
Musculoskeletal Effects of Altered GH Action.生长激素作用改变对肌肉骨骼系统的影响。
Front Physiol. 2022 May 19;13:867921. doi: 10.3389/fphys.2022.867921. eCollection 2022.
3
Sex difference in patients with controlled acromegaly-A multicentre survey.
肢端肥大症患者的性别差异:一项多中心调查。
Clin Endocrinol (Oxf). 2023 Jan;98(1):74-81. doi: 10.1111/cen.14750. Epub 2022 May 4.
4
Diabetes mellitus induced by somatostatin analogue therapy is not permanent in acromegalic patients.生长抑素类似物治疗诱导的糖尿病在肢端肥大症患者中并非永久性的。
Endocrinol Diabetes Metab. 2018 Oct 5;2(1):e00033. doi: 10.1002/edm2.33. eCollection 2019 Jan.